Treatment of experimental endocarditis due to ampicillin-susceptible or ampicillin-resistant Salmonella enteritidis

Manuel L. Fernández Guerrero(Hospital Universitario Fundación Jiménez Díaz), Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Rafael Torres Perea(Hospital Universitario Fundación Jiménez Díaz), C Verdejo Morcillo(Hospital Universitario Fundación Jiménez Díaz), Ricardo Fernández Roblas(Hospital Universitario Fundación Jiménez Díaz)
Antimicrobial Agents and Chemotherapy
July 1, 1996
10.1128/aac.40.7.1589
Cited by 8

Related Papers

Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain
|PLoS ONE|2018|179
Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators
|The Journal of Infectious Diseases|2007|173
Hospital-Acquired Infectious Endocarditis Not Associated with Cardiac Surgery: An Emerging Problem
|Clinical Infectious Diseases|1995|170
The Spectrum of Cardiovascular Infections due to Salmonella enterica
|Medicine|2004|155
Initial Use of Echinocandins Does Not Negatively Influence Outcome in Candida parapsilosis Bloodstream Infection: A Propensity Score Analysis
|Clinical Infectious Diseases|2014|124